Literature DB >> 4559405

Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.

T Ohnuma, J F Holland, P Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4559405     DOI： 10.1002/1097-0142(197208)30:2<376::aid-cncr2820300212>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Authors:  Joanne Kurtzberg; Barbara Asselin; Mark Bernstein; George R Buchanan; Brad H Pollock; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2011-12       Impact factor: 1.289

Review 2.  Asparagine synthetase chemotherapy.

Authors:  Nigel G J Richards; Michael S Kilberg
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.

Authors:  Lynda M Vrooman; Jeffrey G Supko; Donna S Neuberg; Barbara L Asselin; Uma H Athale; Luis Clavell; Kara M Kelly; Caroline Laverdière; Bruno Michon; Marshall Schorin; Harvey J Cohen; Stephen E Sallan; Lewis B Silverman
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

4.  Purification and properties of L-glutaminase-L-asparaginase from Pseudomonas acidovorans.

Authors:  L Davidson; D R Brear; P Wingard; J Hawkins; G B Kitto
Journal:  J Bacteriol       Date:  1977-03       Impact factor: 3.490

Review 5.  Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.

Authors:  Luke Maese; Rachel E Rau
Journal:  Front Pediatr       Date:  2022-06-30       Impact factor: 3.569
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.